Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Supriya Lifescience Ltd

Pharmaceuticals & Biotechnology | Small Cap

Supriya Lifescience Ltd Health Insights
Health Score : 7.46Health Score : 7.46

Supriya Lifescience Ltd demonstrates a strong financial standing, particularly in solvency, growth, coverage, and profitability. The company efficiently manages its debt and showcases impressive growth in revenue, operating profit, and earnings per share. Its ability to cover interest and dividends is also remarkable. Profitability metrics, including gross profit margin, return on capital employed, and return on assets, reflect solid performance. However, efficiency ratios indicate potential challenges in fixed asset, inventory, and capital turnover. While liquidity is generally healthy, there's room to optimize cash management. Overall, Supriya Lifescience exhibits a robust and promising financial profile, balanced by the need for improved asset utilization.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Supriya Lifescience Ltd Health Insights
Health Score : 7.46Health Score : 7.46

Supriya Lifescience Ltd demonstrates a strong financial standing, particularly in solvency, growth, coverage, and profitability. The company efficiently manages its debt and showcases impressive growth in revenue, operating profit, and earnings per share. Its ability to cover interest and dividends is also remarkable. Profitability metrics, including gross profit margin, return on capital employed, and return on assets, reflect solid performance. However, efficiency ratios indicate potential challenges in fixed asset, inventory, and capital turnover. While liquidity is generally healthy, there's room to optimize cash management. Overall, Supriya Lifescience exhibits a robust and promising financial profile, balanced by the need for improved asset utilization.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Highly Overvalued

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Highly Overvalued

P/E RATIO (TTM)

35.88

Overvalued

Industry Median

28.62

Overvalued
Overvalued

Small Cap Median

27.17

Overvalued

P/E RATIO

35.88

P/B RATIO

6.26

Highly Overvalued

Industry Median

3.17

Highly Overvalued
Highly Overvalued

Small Cap Median

2.62

Highly Overvalued

P/S RATIO

8.97

Highly Overvalued

Industry Median

3.42

Highly Overvalued
Highly Overvalued

Small Cap Median

2.55

Highly Overvalued

Others

Overvalued

PEG RATIO

3.26

Overvalued
Overvalued

EV/EBITDA RATIO

24.12

Overvalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹932.2 as on Jun 19, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 10.00

The company demonstrates excellent growth across various metrics, including revenue, operating profit, earnings per share, assets, and net income. This consistent growth indicates strong market performance and effective management strategies. This growth indicates the company is doing well.

ExcellentRevenue Growth RateExcellent
ExcellentOperating Profit Growth RateExcellent
ExcellentEarnings Per Share (EPS) GrowthExcellent
ExcellentAsset Growth RateExcellent
ExcellentNet Income Growth RateExcellent
Growth RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue Growth Rate35.55-13.0223.6422.1118.97
Operating Profit Growth Rate23.7-39.7236.4348.312.64
Earnings Per Share (EPS) Growth11.66-40.7732.557.7711.26
Asset Growth Rate65.1711.5612.3220.7422.03
Net Income Growth Rate22.58-40.7932.2257.9811.17
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 4.40

The company's financial ratios present a mixed picture. Adjusted and cash earnings per share are at an average level, reflecting reasonable profitability per share. Book value per share also indicates a moderate level of shareholder equity. However, dividend per share is low, and capital expenditures are high, suggesting that the company is investing heavily in its operations rather than distributing profits to shareholders. This heavy investing for operation can be risky.

AverageAdjusted Earnings Per Share (Adjusted EPS)Average
AverageCash Earnings Per Share (Cash EPS)Average
AverageBook Value Per ShareAverage
PoorDividend Per Share (DPS)Poor
PoorCapital Expenditures (CapEx)Poor
Financial RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)1911.2514.8823.526.12
Cash Earnings Per Share (Cash EPS)20.2512.7516.882629.62
Book Value Per Share7787.38101.88124.62149.75
Dividend Per Share (DPS)0.570.560.740.931.04
Capital Expenditures (CapEx)60108146162
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 10.00

The company exhibits excellent profitability ratios, including gross profit margin, return on capital employed, return on equity, return on assets, operating margin, and net margin. This consistently high profitability indicates effective cost management, efficient asset utilization, and strong overall financial performance. This reflects effective management and strong financial health.

ExcellentGross Profit MarginExcellent
ExcellentReturn on Capital Employed (ROCE)Excellent
ExcellentReturn on Equity (ROE)Excellent
ExcellentReturn on Assets (ROA)Excellent
ExcellentOperating MarginExcellent
ExcellentNet MarginExcellent
Profitability RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Profit Margin38.4925.3828.0734.6332.13
Return on Capital Employed (ROCE)4319222725
Return on Equity (ROE)24.6812.8814.618.8617.45
Return on Assets (ROA)29.1215.7319.1123.4721.67
Operating Margin40.3827.9830.8837.535.51
Net Margin28.6819.5220.8827.0125.24
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 3.33

The company's efficiency ratios suggest some challenges in asset utilization. While the receivables turnover is average, the fixed asset turnover and capital turnover are lower than ideal, indicating potential inefficiencies in generating revenue from fixed assets and overall capital. High days sales in inventory also suggest slow-moving inventory, which could tie up working capital.

PoorFixed Asset Turnover RatioPoor
WeakInventory Turnover RatioWeak
AverageReceivables Turnover RatioAverage
PoorDays Sales in Inventory RatioPoor
WeakReceivable DaysWeak
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio2.791.761.841.541.2
Inventory Turnover Ratio3.983.314.084.494.04
Receivables Turnover Ratio5.614.615.795.664.69
Days Sales in Inventory Ratio91.71110.2789.4681.2990.35
Receivable Days65.0679.1863.0464.4977.83
Capital Turnover Ratio0.850.650.690.690.69
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 10.00

The company demonstrates excellent coverage ratios, indicating a strong ability to meet its interest and dividend obligations. High interest coverage suggests the company can easily pay its interest expenses, while strong equity dividend coverage shows it can comfortably meet its dividend payments. This indicates a strong level of financial security.

ExcellentInterest Coverage RatioExcellent
ExcellentEquity Dividend Coverage RatioExcellent
Coverage RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Interest Coverage Ratio52.754234.2125138.5
Equity Dividend Coverage Ratio33.3320202525
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 10.00

The company exhibits excellent solvency, indicating a very low level of debt relative to its equity and assets. This conservative capital structure suggests minimal financial risk and a strong capacity to meet its long-term obligations. This provides substantial financial stability.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
ExcellentEquity RatioExcellent
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debt Ratio0.010.010.010.010
Debt to Equity Ratio0.010.010.010.010
Equity Ratio0.990.990.990.991
Debt To Asset Ratio0.010.010.0100
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 9.18

The company's liquidity position is generally strong, indicating a good ability to meet its short-term obligations. The current and quick ratios demonstrate sufficient liquid assets. However, the cash ratio indicates a moderate level of immediately available cash, and the operating cash flow ratio suggests that the company generates a reasonable amount of cash from its operations. A higher cash ratio would provide more financial flexibility.

ExcellentCurrent RatioExcellent
ExcellentQuick RatioExcellent
GoodCash RatioGood
GoodOperating Cash Flow RatioGood
Liquidity RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Current Ratio4.434.073.954.073.47
Quick Ratio3.623.053.1132.43
Cash Ratio2.011.380.740.720.51
Operating Cash Flow Ratio0.430.561.121.50
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 22 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1FDC Ltd7.6422.52Neutral346.0017.56281.00
2Supriya Lifescience Ltd7.4635.88Highly Overvalued294.0025.98209.00
3Aarti Pharmalabs Ltd7.4635.90Neutral369.0019.44175.00
4Innova Captab Ltd7.3638.55Overvalued243.0014.63141.00
5Akums Drugs & Pharmaceuticals Ltd7.2837.30Overvalued522.007.09256.00
6Marksans Pharma Ltd7.2428.16Neutral601.006.64420.00
7Hikal Ltd7.13-51.71Neutral220.00-3.95-49.00
8RPG Life Sciences Ltd7.1232.70Neutral147.0069.64115.00
9Alembic Ltd7.067.28Undervalued90.004.85317.00
10SMS Pharmaceuticals Ltd5.9434.77Neutral171.009.35102.00
11Shilpa Medicare Ltd5.9444.32Highly Overvalued435.006.80243.00
12Strides Pharma Science Ltd5.5518.41Undervalued925.0019.92575.00
13Jeena Sikho Lifecare Ltd5.5231.22Neutral349.0017.87222.00
14Gufic BioSciences Ltd5.4955.51Neutral151.006.3064.00
15Dishman Carbogen Amcis Ltd5.3827.45Neutral566.00-2.4597.00
16IOL Chemicals & Pharmaceuticals Ltd5.3127.76Undervalued269.004.69138.00
17Aarti Drugs Ltd5.0717.34Undervalued309.0018.54195.00
18Orchid Pharma Ltd4.85241.74Neutral41.008.9121.00
19Sequent Scientific Ltd4.61293.05Overvalued162.000.6332.00
20Sun Pharma Advanced Research Company Ltd4.354.97Neutral1599.0047.831553.00
21Zota Health Care Ltd3.97-61.25Neutral19.008.06-74.00
22Procter & Gamble Health Ltd3.4531.71Neutral457.00196.94327.00
Management Assessment Summary
OrangeBalanced Management

The management of Supriya Lifescience presents a mixed performance. Strong profit growth and a high promoter holding are positive indicators. However, fluctuating sales growth and high inventory days raise concerns. The company demonstrates good capital efficiency but needs to address inconsistencies in revenue expansion and working capital management to enhance overall performance.

Category Metric Value Assessment
PROS Strong Profit Growth 58% Excellent profit growth
High Promoter Holding 68.30% Indicates confidence and alignment
Good ROCE 27% Capital is being used productively
CONS Fluctuating Sales Growth -13.04% to 35.49% Inconsistent revenue expansion
High Inventory Days 205 Operational inefficiencies in working capital management
AverageFinancial Performance & GrowthAverage
GoodCapital Efficiency & ReturnsGood
ExcellentFinancial Health & PrudenceExcellent
WeakStrategic & Operational IndicatorsWeak
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Strategic & Operational Indicators

Risk Assessment Summary
OrangeBalanced Risk

The risk assessment for Supriya Lifescience indicates a moderate level of risk due to the absence of specific data on key evaluation areas. The absence of data makes it difficult to fully assess the company's risk exposure. A balanced approach to risk management is necessary to address the identified vulnerabilities effectively.

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10933.50Bearish
  3. SMA 20931.76Bullish
  4. SMA 50949.06Bearish
  5. EMA 10933.34Bearish
  6. EMA 20935.46Bearish
  7. EMA 50940.79Bearish
  8. DEMA 10932.77Bearish
  9. DEMA 20929.67Bullish
  10. DEMA 50942.77Bearish
  11. TEMA 10934.17Bearish
  12. TEMA 20930.83Bullish
  13. TEMA 50923.95Bullish
  14. MACD-3.77Bullish
  15. ADX15.56Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI45.56Neutral
  3. CCI12.61Neutral
  4. ROC 90.34Bullish
  5. ROC 141.74Bullish
  6. ROC 25-0.92Bearish
  7. Stoch K56.15Neutral
  8. Stoch D60.16Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper946.54Neutral
  3. BB Middle931.75Neutral
  4. BB Lower916.97Neutral
  5. ATR10.82Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI71.81Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10929.70Bullish
  3. SMA 20939.96Bearish
  4. SMA 50946.94Bearish
  5. EMA 10934.20Bearish
  6. EMA 20938.59Bearish
  7. EMA 50929.36Bullish
  8. DEMA 10930.49Bullish
  9. DEMA 20932.54Bearish
  10. DEMA 50967.48Bearish
  11. TEMA 10932.59Bearish
  12. TEMA 20925.10Bullish
  13. TEMA 50945.29Bearish
  14. MACD-4.60Bearish
  15. ADX23.36Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI46.31Neutral
  3. CCI-45.58Neutral
  4. ROC 92.09Bullish
  5. ROC 14-0.77Bearish
  6. ROC 25-0.43Bearish
  7. Stoch K45.83Neutral
  8. Stoch D44.34Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper967.85Neutral
  3. BB Middle939.96Neutral
  4. BB Lower912.06Neutral
  5. ATR16.70Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI50.70Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10937.81Bearish
  3. SMA 20947.59Bearish
  4. SMA 50874.64Bullish
  5. EMA 10937.04Bearish
  6. EMA 20934.77Bearish
  7. EMA 50880.80Bullish
  8. DEMA 10931.04Bullish
  9. DEMA 20954.46Bearish
  10. DEMA 50976.17Bearish
  11. TEMA 10924.53Bullish
  12. TEMA 20931.45Bullish
  13. TEMA 50N/AN/A
  14. MACD11.37Bearish
  15. ADX33.53Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI51.91Neutral
  3. CCI-76.67Neutral
  4. ROC 9-3.27Bearish
  5. ROC 14-4.41Bearish
  6. ROC 254.07Bullish
  7. Stoch K23.65Neutral
  8. Stoch D20.89Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper986.79Neutral
  3. BB Middle947.59Neutral
  4. BB Lower908.39Neutral
  5. ATR29.84Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI34.69Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 10944.52Bearish
  3. SMA 20904.95Bullish
  4. SMA 50764.68Bullish
  5. SMA 100703.82Bullish
  6. SMA 200717.13Bullish
  7. EMA 10932.71Bearish
  8. EMA 20895.46Bullish
  9. EMA 50804.25Bullish
  10. EMA 100750.53Bullish
  11. EMA 200719.80Bullish
  12. DEMA 10955.38Bearish
  13. DEMA 20973.40Bearish
  14. DEMA 50900.42Bullish
  15. DEMA 100805.43Bullish
  16. DEMA 200764.39Bullish
  17. TEMA 10935.30Bearish
  18. TEMA 20977.69Bearish
  19. TEMA 50968.95Bearish
  20. TEMA 100860.63Bullish
  21. TEMA 200766.07Bullish
  22. MACD55.11Bearish
  23. ADX45.20Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI58.48Neutral
  3. CCI25.58Neutral
  4. ROC 14-3.76Bearish
  5. ROC 2536.32Bullish
  6. Stoch K35.81Neutral
  7. Stoch D47.65Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper1070.97Neutral
  3. BB Middle904.95Neutral
  4. BB Lower738.93Neutral
  5. ATR50.97Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI64.64Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 20700.96Bullish
  3. SMA 50711.27Bullish
  4. EMA 20752.47Bullish
  5. EMA 50710.24Bullish
  6. DEMA 20809.31Bullish
  7. DEMA 50763.24Bullish
  8. TEMA 20865.70Bullish
  9. TEMA 50754.72Bullish
  10. MACD53.57Bullish
  11. ADX27.85Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI71.20Overbought
  3. CCI302.65Overbought
  4. ROC 1455.62Bullish
  5. ROC 2532.43Bullish
  6. Stoch K84.87Overbought
  7. Stoch D87.76Overbought
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper940.06Overbought
  3. BB Middle700.96Neutral
  4. BB Lower461.85Neutral
  5. ATR78.69High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI82.18Overbought

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 6718.01Bullish
  3. SMA 12715.38Bullish
  4. SMA 24668.32Bullish
  5. EMA 6754.96Bullish
  6. EMA 12716.72Bullish
  7. EMA 24651.03Bullish
  8. DEMA 6804.52Bullish
  9. DEMA 12776.82Bullish
  10. DEMA 24790.47Bullish
  11. TEMA 6842.79Bullish
  12. TEMA 12773.86Bullish
  13. TEMA 24N/AN/A
  14. MACDN/AN/A
  15. ADX34.69Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI61.83Neutral
  3. CCI139.18Overbought
  4. ROC 25144.22Bullish
  5. ROC 5096.37Bullish
  6. Stoch K73.97Neutral
  7. Stoch D77.96Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper872.89Overbought
  3. BB Middle707.23Neutral
  4. BB Lower541.57Neutral
  5. ATR129.43High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI66.82Neutral